Formulation and Evaluation of Optimized Zaltoprofen Lyophilized Tablets by Zydis Technique

Q3 Pharmacology, Toxicology and Pharmaceutics Iraqi Journal of Pharmaceutical Sciences Pub Date : 2017-07-12 DOI:10.1234/IJPS.V26I1.684
Suray A. Hazzaa, Shaimaa N. Abd-Alhameed
{"title":"Formulation and Evaluation of Optimized Zaltoprofen Lyophilized Tablets by Zydis Technique","authors":"Suray A. Hazzaa, Shaimaa N. Abd-Alhameed","doi":"10.1234/IJPS.V26I1.684","DOIUrl":null,"url":null,"abstract":"“Orodispersible Tablet” a tablet that is to be placed in oral cavity where it disperses rapidly by saliva with no need for water before swallowing. Zaltoprofen (ZLP) is one of NSAIDs which is used in the treatment of rheumatoid arthritis and osteoarthritis as well as to relieve inflammation and pain after surgery, injury and tooth extraction. The present study was aimed to prepare rapidly dissolved lyophilized Zaltoprofen tablet with different pharmaceutical excipients and studying the factors affecting pharmaceutical properties like (solubility, disintegration time DT, dissolution, etc.) of tablets. The lyophilized disintegrating tablets (LDTs) were prepared using Zydis technique by lyophilization an aqueous dispersion of Zaltoprofen with a matrix forming agent, gelatin, and a collapse protectant, glycine. In addition to many excipients like PVPK30 was used to improve the in vitro, in vivo disintegration time and dissolution rate, mannitol as bulk forming agent. Fourteen formulations were prepared to inspect the variables that affect the disintegration time and dissolution rate.  All the formulations were evaluated for their physical appearance, mechanical strength, X-ray diffraction, FTIR, DT, and in vitro drug release. The prepared tablets were optimized and formula was subjected to different measured parameters such as disintegration time, Drug content, and in-vitro drug release. Results obtained from dissolution studies and DT showed that lyophilized disintegrating tablets (LDTs) (F8,F10,F12,F13 was 45,37,21 and 17 Sec.) respectively ,while(F14) displayed considerably faster in vitro dissolution rate of (Zaltoprofen) 3 min. and DT 9 sec. The (lyophilized disintegrating tablets) were also evaluated showing the transformation into amorphous state and absence of interaction of Zaltoprofen with the components of the tablets. From visual inspection ,physical strength ,DT and release behavior obtained ,one can conclude that the formulas(F14) which contains Zaltoprofen 3.2% ,gelatin3%, mannitol 3%, glycine 1.5%, PVP K30 1.5% was the most suitable one. \nKeywords : Zaltoprofen, lyophilization, PVPK30 .","PeriodicalId":14600,"journal":{"name":"Iraqi Journal of Pharmaceutical Sciences","volume":"26 1","pages":"40-49"},"PeriodicalIF":0.0000,"publicationDate":"2017-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iraqi Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1234/IJPS.V26I1.684","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 2

Abstract

“Orodispersible Tablet” a tablet that is to be placed in oral cavity where it disperses rapidly by saliva with no need for water before swallowing. Zaltoprofen (ZLP) is one of NSAIDs which is used in the treatment of rheumatoid arthritis and osteoarthritis as well as to relieve inflammation and pain after surgery, injury and tooth extraction. The present study was aimed to prepare rapidly dissolved lyophilized Zaltoprofen tablet with different pharmaceutical excipients and studying the factors affecting pharmaceutical properties like (solubility, disintegration time DT, dissolution, etc.) of tablets. The lyophilized disintegrating tablets (LDTs) were prepared using Zydis technique by lyophilization an aqueous dispersion of Zaltoprofen with a matrix forming agent, gelatin, and a collapse protectant, glycine. In addition to many excipients like PVPK30 was used to improve the in vitro, in vivo disintegration time and dissolution rate, mannitol as bulk forming agent. Fourteen formulations were prepared to inspect the variables that affect the disintegration time and dissolution rate.  All the formulations were evaluated for their physical appearance, mechanical strength, X-ray diffraction, FTIR, DT, and in vitro drug release. The prepared tablets were optimized and formula was subjected to different measured parameters such as disintegration time, Drug content, and in-vitro drug release. Results obtained from dissolution studies and DT showed that lyophilized disintegrating tablets (LDTs) (F8,F10,F12,F13 was 45,37,21 and 17 Sec.) respectively ,while(F14) displayed considerably faster in vitro dissolution rate of (Zaltoprofen) 3 min. and DT 9 sec. The (lyophilized disintegrating tablets) were also evaluated showing the transformation into amorphous state and absence of interaction of Zaltoprofen with the components of the tablets. From visual inspection ,physical strength ,DT and release behavior obtained ,one can conclude that the formulas(F14) which contains Zaltoprofen 3.2% ,gelatin3%, mannitol 3%, glycine 1.5%, PVP K30 1.5% was the most suitable one. Keywords : Zaltoprofen, lyophilization, PVPK30 .
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Zydis技术优化Zaltoprofen冻干片的处方及评价
“口服分散片”是一种放置在口腔中的片剂,在吞咽前通过唾液快速分散,不需要水。Zaltoprofen(ZLP)是一种非甾体抗炎药,用于治疗类风湿性关节炎和骨关节炎,以及缓解手术、损伤和拔牙后的炎症和疼痛。本研究旨在用不同的药用辅料制备快速溶解的冻干Zaltoprofen片剂,并研究影响片剂药物性质的因素,如溶解度、崩解时间DT、溶出度等。使用Zydis技术,通过将Zaltoprofen的水分散体与基质形成剂明胶和崩解保护剂甘氨酸冷冻干燥,制备冻干崩解片(LDTs)。除了使用许多赋形剂如PVPK30来改善体外、体内崩解时间和溶解速率外,甘露醇作为本体形成剂。制备了14种制剂,以检查影响崩解时间和溶解速率的变量。对所有制剂的物理外观、机械强度、X射线衍射、FTIR、DT和体外药物释放进行了评估。对制备的片剂进行了优化,并对配方进行了不同的测定参数,如崩解时间、药物含量和体外药物释放。从溶出度研究和DT获得的结果表明,冻干崩解片(LDTs)(F8,F10,F12,F13分别为45,37,21和17秒),而(F14)显示出明显更快的体外溶出速率(Zaltoprofen)3分钟和DT 9秒。还对(冻干崩解片)进行了评价,显示其转变为无定形状态,并且Zaltoprofen与片剂成分没有相互作用。从外观检查、物理强度、DT和释放行为可以得出结论,含有3.2%Zaltoprofen、3%明胶、3%甘露醇、1.5%甘氨酸、1.5%PVP K30的配方(F14)是最合适的配方。关键词:Zaltoprofen,冷冻干燥,PVPK30。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Iraqi Journal of Pharmaceutical Sciences
Iraqi Journal of Pharmaceutical Sciences Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.40
自引率
0.00%
发文量
37
审稿时长
24 weeks
期刊最新文献
Formulation and in vitro /in vivo Evaluation of Silymarin Solid Dispersion- Based Topical Gel for Wound Healing Assessment of ellagic acid action in 5-fluorouracil induced intestinal mucositis Possible Anti-Asthmatic Effect of Iraqi Ammi Majus Seeds Extract Against Asthma Induced by Ovalbumin in Mice Effectiveness of Myoinositol alone or in Companion with Metformin in Improving Hormonal, Metabolic, and Clinical Features of PCOS Women Preparation and characterization of Posaconazole as a Nano-micelles using d-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1